Institute of Hematology Arthur Siqueira Cavalcanti (HEMORIO), Rio de Janeiro, RJ, Brazil.
Fluminense Federal University, Niteroi, Rio de Janeiro, RJ, Brazil.
Pan Afr Med J. 2024 Feb 28;47:93. doi: 10.11604/pamj.2024.47.93.32594. eCollection 2024.
Essential thrombocythemia is the category of myeloproliferative syndromes, generally characterized by a group of clonal stem cell diseases that present a disturbance in the growth of one or more sets of hematopoietic cells. All long clinical treatment, patients may experience gastrointestinal disorders and other metabolic processes that can lead to weight loss and malnutrition. Cytokine is involved in the control of appetite, digestive, and metabolic processes in the body, it can be assumed that increased stimulation could impair the control of these processes leading to loss of body mass. Effective and systematic nutritional intervention is required to ensure patient compliance with treatment and improved nutritional status.
原发性血小板增多症属于骨髓增殖性肿瘤范畴,通常表现为一组克隆性造血干细胞疾病,其特征为一个或多个造血细胞系生长异常。在长期的临床治疗中,患者可能会出现胃肠道紊乱等代谢过程,从而导致体重减轻和营养不良。细胞因子参与控制身体的食欲、消化和代谢过程,可以推测,过度刺激可能会损害这些过程的控制,导致体重下降。需要进行有效的系统营养干预,以确保患者遵医嘱治疗和改善营养状况。